BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

876 related articles for article (PubMed ID: 32384893)

  • 1. LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis.
    Liang Y; Song X; Li Y; Chen B; Zhao W; Wang L; Zhang H; Liu Y; Han D; Zhang N; Ma T; Wang Y; Ye F; Luo D; Li X; Yang Q
    Mol Cancer; 2020 May; 19(1):85. PubMed ID: 32384893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of long noncoding RNA TP73-AS1 suppresses the malignant progression of breast cancer cells in vitro through targeting miRNA-125a-3p/metadherin axis.
    Liu Y; Wei G; Ma Q; Han Y
    Thorac Cancer; 2020 Feb; 11(2):394-407. PubMed ID: 31901156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA nuclear-enriched abundant transcript 1 promotes cell proliferation and invasion by targeting miR-186-5p/HIF-1α in osteosarcoma.
    Tan H; Zhao L
    J Cell Biochem; 2019 Apr; 120(4):6502-6514. PubMed ID: 30485482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTBP3-Mediated Regulation of ZEB1 mRNA Stability Promotes Epithelial-Mesenchymal Transition in Breast Cancer.
    Hou P; Li L; Chen F; Chen Y; Liu H; Li J; Bai J; Zheng J
    Cancer Res; 2018 Jan; 78(2):387-398. PubMed ID: 29187406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA RP11-283G6.5 confines breast cancer development through modulating miR-188-3p/TMED3/Wnt/β-catenin signalling.
    Pei J; Zhang S; Yang X; Han C; Pan Y; Li J; Wang Z; Sun C; Zhang J
    RNA Biol; 2021 Oct; 18(sup1):287-302. PubMed ID: 34130584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway.
    Qiao K; Ning S; Wan L; Wu H; Wang Q; Zhang X; Xu S; Pang D
    J Exp Clin Cancer Res; 2019 Oct; 38(1):418. PubMed ID: 31623640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circ-UBR1 facilitates proliferation, metastasis, and inhibits apoptosis in breast cancer by regulating the miR-1299/CCND1 axis.
    Zhang L; Sun D; Zhang J; Tian Y
    Life Sci; 2021 Feb; 266():118829. PubMed ID: 33259864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
    Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
    Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
    J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The knockdown of LncRNA AFAP1-AS1 suppressed cell proliferation, migration, and invasion, and promoted apoptosis by regulating miR-545-3p/hepatoma-derived growth factor axis in lung cancer.
    Sun J; Min H; Yu L; Yu G; Shi Y; Sun J
    Anticancer Drugs; 2021 Jan; 32(1):11-21. PubMed ID: 33290312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TUG1 knockdown inhibits the tumorigenesis and progression of prostate cancer by regulating microRNA-496/Wnt/β-catenin pathway.
    Li G; Yang J; Chong T; Huang Y; Liu Y; Li H
    Anticancer Drugs; 2020 Jul; 31(6):592-600. PubMed ID: 32427740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H3K27 acetylation-induced lncRNA EIF3J-AS1 improved proliferation and impeded apoptosis of colorectal cancer through miR-3163/YAP1 axis.
    Liu D; Zhang H; Cong J; Cui M; Ma M; Zhang F; Sun H; Chen C
    J Cell Biochem; 2020 Feb; 121(2):1923-1933. PubMed ID: 31709617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis.
    Wu X; Kong C; Wu Y
    Bioengineered; 2021 Dec; 12(1):9046-9057. PubMed ID: 34657558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA RP11-626G11.3 promotes the progression of glioma through miR-375-SP1 axis.
    Zhang Y; Mou C; Shang M; Jiang M; Xu C
    Mol Carcinog; 2020 May; 59(5):492-502. PubMed ID: 32128886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p.
    Yang C; Wu K; Wang S; Wei G
    J Cell Biochem; 2018 Jul; 119(7):5646-5656. PubMed ID: 29384226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis.
    Hu YP; Jin YP; Wu XS; Yang Y; Li YS; Li HF; Xiang SS; Song XL; Jiang L; Zhang YJ; Huang W; Chen SL; Liu FT; Chen C; Zhu Q; Chen HZ; Shao R; Liu YB
    Mol Cancer; 2019 Nov; 18(1):167. PubMed ID: 31752906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomal lncRNA HMMR-AS1 mediates macrophage polarization through miR-147a/ARID3A axis under hypoxia and affects the progression of hepatocellular carcinoma.
    Wang X; Zhou Y; Dong K; Zhang H; Gong J; Wang S
    Environ Toxicol; 2022 Jun; 37(6):1357-1372. PubMed ID: 35179300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The circular RNA circ-ERBIN promotes growth and metastasis of colorectal cancer by miR-125a-5p and miR-138-5p/4EBP-1 mediated cap-independent HIF-1α translation.
    Chen LY; Wang L; Ren YX; Pang Z; Liu Y; Sun XD; Tu J; Zhi Z; Qin Y; Sun LN; Li JM
    Mol Cancer; 2020 Nov; 19(1):164. PubMed ID: 33225938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.